Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 1-6.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Shoukat A, Wells CR, Langley JM, Singer BH, Galvani AP, Moghadas SM, Projecting demand for critical care beds during COVID-19 outbreaks in Canada, Canadian Medical Association Journal 2020, 192(19): E489–E496.
Wells CR, Fitzpatrick MC, Sah P, Shoukat A, Pandey A, El-Sayed AM, Moghadas SM, Galvani AP, Projecting the demand for ventilators at the peak of COVID-19 outbreaks in the United States, The Lancet Infectious Diseases 2020, S1473-3099(20): 30315–30317.
Venturino E, Shoukat A, Moghadas SM, Dynamics of HSV-2 infection with a therapeutic vaccine, Heliyon 2020, 6: e04368.
Wells CR, Sah P, Moghadas SM, Shoukat A, Wang Y, Pandey A, Singer BH, Galvani AP, Impact of international travel and border control measures on the global spread of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(13):7504–7509.
Champredon D, Shoukat A, Moghadas SM, Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting, Vaccine 2020, 38: 2585–2591.
Champredon D, Shoukat A, Singer BH, Galvani AP, Moghadas SM, Curbing the 2019 Samoa measles outbreak, The Lancet Infectious Diseases 2020, 20: 287–288.
Shoukat A, Moghadas SM, Agent-based modelling: an overview with application to infectious disease dynamics 2020, arXiv:2007.04192.
Shoukat A, Vilches T, Moghadas SM, Cost-effectiveness of prophylactic Zika virus vaccine in the Americas, Emerging Infectious Diseases 2019, 12: 2191–2196.
Champredon D, Zhang K, Smieja M, Moghadas SM, Clostridium difficile intervention timelines for diagnosis, isolation, and treatment, American Journal of Infection Control 2019, 47: 1370–1374.
Wang Z, Röst G, Moghadas SM, Delay in booster schedule as a control parameter in vaccination dynamics, Journal of Mathematical Biology 2019, 79: 2157–2182.